Download Free Psychiatric Drugs Explained 5e Book in PDF and EPUB Free Download. You can read online Psychiatric Drugs Explained 5e and write the review.

This version is now out of print. An edition with e-book is available under ISBN 97880702041365. Psychiatric Drugs Explained contains a clear and comprehensive guide to the uses, benefits and impact of psychotropic drugs. It explains how people taking the drugs experience their side effects compared to the benefits they may bring. The fifth edition has been fully revised and updated to include the latest thinking on the rationale for drug treatements to help mental health professionals and service users understand therapeutic decision making. * Organized by disorder * Comprehensive review of drug effects, action and side-effects * 'User issues' boxes to highlight particular problems experienced * Website addresses to allow searching for further information * Questionnaires to help assess side effects Information on: * New antipsychotic drugs and metabolic complications * New antidepressants * How drugs and therapies such as cognitive behavioural therapy interact and compete * Drugs that affect sexual functioning * Evidence-based medicine
This book offers a comprehensive survey of the current state of knowledge in the field of neuro-psychopharmacology in childhood and adolescence. In the first part, the essentials of neuro-psychopharmacology are presented in order to provide a deeper understanding of the principles and particularities in the pharmacotherapy of children and adolescents. This part includes information on neurotransmitters and signal transduction pathways, molecular brain structures as targets for psychiatric drugs, characteristics of psychopharmacological therapy in children and adolescents, ontogenetic influences on pharmacokinetics and pharmacodynamics, and pharmacotherapy in the outpatient setting. The part on classes of psychiatric medications, which covers antidepressants, antipsychotics, anxiolytics and sedative-hypnotics, mood stabilizers, and psychostimulants and other drugs used in the treatment of attention-deficit/hyperactivity disorder, provides sufficient background material to better understand how psychoactive drugs work, and why, when, and for whom they should be used. For each drug within a class, information on its mechanisms of action, clinical pharmacology, indications, dosages, and cognate issues are reviewed. In the third part, the disorder-specific and symptom-oriented medication is described and discerningly evaluated from a practical point of view, providing physicians with precise instructions on how to proceed. Psychiatric Drugs in Children and Adolescents includes numerous tables, figures and illustrations and offers a valuable reference work for child and adolescent psychiatrists and psychotherapists, pediatricians, general practitioners, psychologists, and nursing staff, as well as teachers.
Elsevier now offers a series of derivative works based on the acclaimed Meylers Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing physician or health care clinician. The unwarranted effects of medications used in psychiatry can adversely affect a treatment plan. This book is critical in helping psychiatrists and mental health professionals assess the adverse effects of drugs such as antidepressants, mood stabilizers, hypnosedatives, and antipsychotic drugs. The material is drawn from the 15th edition of the internationally renowned encyclopedia, Meyler’s Side Effects of Drugs, and the latest volumes in the companion series, Side Effects of Drugs Annuals. Drug names have usually been designated by their recommended or proposed International Non-proprietary Names (rINN or pINN); when those are not available, clinical names have been used. In some cases, brand names have been used. This volume is critical for any health professional involved in the administration of psychiatric mediations. Surpasses the Physician’s Desk Reference © by including clinical case studies and independent expert analysis Complete index of drug names Most complete cross referencing of drug-drug interactions available Extensive references to primary and secondary literature Also includes information on adverse effects in pregnancy The book is divided into six sections: Antidepressants – A general introduction to their adverse effects, followed by monographs on individual drugs and groups of drugs (including lithium) Neuroleptic drugs – A general introduction to their adverse effects, followed by monographs on individual drugs Hypnosedatives - A general introduction to their adverse effects, followed by monographs on individual drugs Drugs of abuse Drugs used to treat Alzheimer’s disease Psychological and psychiatric adverse effects of non-psychoactive drugs
The Intelligent Clinician's Guide to the DSM-5 examines the latest version of the DSM and offers mental health practitioners a critical guide for understanding the positive aspects of DSM-5, but also its limitations. Written in a lively voice by a celebrated professor of psychiatry and featuring the latest in psychiatric research and debate, this book is necessary reading for all mental health practitioners using the DSM.
The Intelligent Clinician's Guide to the DSM-5® is the second edition of the widely-read book first published in 2013. This second edition is thoroughly revised, and has several new chapters describing the response to the publication of the new manual, as well as suggestions on its use in clinical practice. The Intelligent Clinician's Guide to the DSM-5®, Second Edition reviews the history of diagnosis in psychiatry, emphasizing the limitations for classification of our current lack of knowledge of the causes of most mental disorders. It emphasizes that, in the absence of biomarkers, current categories can only be considered provisional. It takes a critical look at schema for spectra and dimensionaliztion of diagnosis, examines the borders between normality and psychopathology, and discusses the problem of clinical utility. The book has chapters on all the major diagnoses in psychiatry, in which the main problems of diagnosis are addressed, and in which all changes in DSM-5 are described.
This is the first book to establish guidelines and to assist prescribers and therapists in withdrawing their patients from psychiatric drugs, including those patients with long-term exposure to antipsychotic drugs, benzodiazepines, stimulants, antidepressants, and mood stabilizers. It describes a method developed by the author throughout years of clinical experience, consultations with experienced colleagues, and scientific research. Based on a person-centered collaborative approach, with patients as partners, this method builds on a cooperative and empathic team effort involving prescribers, therapists, patients, and their families or support network. The author, known for such books as Talking Back to Prozac, Toxic Psychiatry, and Medication Madness, is a lifelong reformer and scientist in mental health whose work has brought about significant change in psychiatric practice. This book provides critical information about when to consider psychiatric drug reduction or withdrawal, and how to accomplish it as safely, expeditiously, and comfortably as possible. It offers the theoretical framework underlying this approach along with extensive scientific information, practical advice, and illustrative case studies that will assist practitioners in multiple ways, including in how to: Recognize common and sometimes overlooked adverse drug effects that may require withdrawal Treat emergencies during drug therapy and during withdrawal Determine the first drugs to withdraw during multi-drug therapy Distinguish between withdrawal reactions, newly occurring emotional problems, and recurrence of premedication issues Estimate the length of withdrawal

Best Books